Skip to main content
Premium Trial:

Request an Annual Quote

Genetic Technologies Settles IP Dispute with Genesis Genetics Institute

NEW YORK (GenomeWeb News) – Genetic Technologies today announced it has settled with Genesis Genetics Institute over GTG's patent covering its non-coding DNA technology.

GTG sued Detroit-based Genesis Genetics in September in US District Court Eastern District of Michigan, Southern Division, alleging Genesis Genetics infringed on US Patent No. 5,612,179 which was assigned by an entity called Genetype AG to GTG.

The patent is at the center of a number of lawsuits that GTG has leveled at competitors alleging infringement, and in July it settled with Reproductive Genetics Institute over similar litigation. That followed a deal between GTG and Bioscientia Institute for Medical Diagnostics in late June to settle a dispute over the '179 patent.

Terms of the settlement announced today were not disclosed.

On Friday, GTG said that New York has issued a Clinical Laboratory Permit to the firm, allowing it to offer its BREVAGen test to residents of the state.

The Scan

Could Mix It Up

The US Food and Drug Administration is considering a plan that would allow for the mixing-and-matching of SARS-CoV-2 vaccines and boosters, the New York Times says.

Closest to the Dog

New Scientist reports that extinct Japanese wolf appears to be the closest known wild relative of dogs.

Offer to Come Back

The Knoxville News Sentinel reports that the University of Tennessee is offering Anming Hu, a professor who was acquitted of charges that he hid ties to China, his position back.

PNAS Papers on Myeloid Differentiation MicroRNAs, Urinary Exosomes, Maize Domestication

In PNAS this week: role of microRNAs in myeloid differentiation, exosomes in urine, and more.